Escitalopram in the treatment of patients with agitated dementia.

Trial Profile

Escitalopram in the treatment of patients with agitated dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2012 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
    • 23 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top